financetom
Business
financetom
/
Business
/
Jabil Fiscal Q4 Core Earnings, Net Revenue Rise; Fiscal Q1, 2026 Outlook Issued
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Jabil Fiscal Q4 Core Earnings, Net Revenue Rise; Fiscal Q1, 2026 Outlook Issued
Sep 25, 2025 5:29 AM

07:58 AM EDT, 09/25/2025 (MT Newswires) -- Jabil ( JBL ) reported fiscal Q4 core earnings Thursday of $3.29 per diluted share, up from $2.30 a year earlier.

Analysts polled by FactSet expected $2.92.

Net revenue for the quarter ended Aug. 31 was $8.25 billion, compared with $6.96 billion a year earlier.

Analysts surveyed by FactSet expected $7.59 billion.

For fiscal 2026, the company said it expects core earnings of $11 per diluted share on revenue of $31.3 billion.

Analysts surveyed by FactSet expect core earnings of $10.81 on revenue of $30.71 billion.

For fiscal Q1, the company said it expects core earnings in the range of $2.47 to $2.87 per share on net revenue of $7.7 billion to $8.3 billion.

Analysts polled by FactSet expect $2.40 and $7.53 billion, respectively.

Shares of the company were down 3.7% in recent premarket activity Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Shell Expects Q1 LNG Business Results to Fall From Q4
Shell Expects Q1 LNG Business Results to Fall From Q4
Apr 5, 2024
05:03 AM EDT, 04/05/2024 (MT Newswires) -- Shell (SHEL) said Friday it expects significantly lower Q1 results in its liquefied natural gas business compared with its exceptional Q4. In an update note, the company said LNG liquefaction volumes are expected to range from 7.2 million metric tons to 7.6 million metric tons in Q1. The energy company also expects to...
Candel Therapeutics Shares Surge Premarket Following 'Positive' Phase 2 Results From Non-Metastatic Pancreatic Cancer Trial
Candel Therapeutics Shares Surge Premarket Following 'Positive' Phase 2 Results From Non-Metastatic Pancreatic Cancer Trial
Apr 5, 2024
04:45 AM EDT, 04/05/2024 (MT Newswires) -- Candel Therapeutics ( CADL ) shares rose more than 24% in premarket activity on Friday, extending gains a day after reporting positive interim data from a randomized phase 2 clinical study of non-metastatic pancreatic cancer. Shares closed 281% higher on Thursday where the company said interim data showed notable improvements. It reported an...
Weak rise in orders points to more gloom for German industry
Weak rise in orders points to more gloom for German industry
Apr 5, 2024
(Reuters) -German industrial orders grew more slowly than expected in February, showing that weak demand in the manufacturing sector continues to drag on Europe's biggest economy. New orders increased by 0.2% on the previous month on a seasonally and calendar adjusted basis, the federal statistics office said on Friday. A Reuters poll of analysts had pointed to a rise of...
Grindrod Shipping's Shares Surge in Premarket Following Plans to Implement Selective Capital Reduction
Grindrod Shipping's Shares Surge in Premarket Following Plans to Implement Selective Capital Reduction
Apr 5, 2024
05:16 AM EDT, 04/05/2024 (MT Newswires) -- Grindrod Shipping ( GRIN ) shares were up over 27% in premarket activity on Friday after the company said it plans to implement a selective capital reduction. The board plans to seek shareholder approval at an extraordinary general meeting for the selective capital reduction. The company proposes to cancel all the shares held...
Copyright 2023-2026 - www.financetom.com All Rights Reserved